started · updated
World COPD Day: Global health experts warn of high undiagnosed rates
On November 18, 2026, health organizations and medical experts marked World COPD Day, highlighting the significant global impact of Chronic Obstructive Pulmonary Disease. The condition is identified as the third leading cause of death worldwide, accounting for over 3 million annual deaths.
A critical issue identified across multiple regions is the high rate of undiagnosed cases. In Spain, approximately 75% of patients are unaware of their condition, while in Canada, roughly 80% of those living with COPD remain undiagnosed. Similarly, in Italy, an estimated 70% of cases are diagnosed late or remain undetected.
Medical professionals emphasize that symptoms such as persistent cough, shortness of breath during physical activity, and frequent phlegm are often mistakenly attributed to aging. Key risk factors include tobacco use, exposure to biomass smoke (such as wood or coal), air pollution, and occupational exposure to dust or chemicals.
Advancements in treatment include the introduction of biological therapies, such as dupilumab and mepolizumab, which target specific inflammatory mechanisms. Experts also stress the importance of early diagnosis through spirometry and the role of respiratory physiotherapy in maintaining patient autonomy and quality of life.
Entities
COPD · Dupilumab · Fenaer · Fuerteventura General Hospital · Global Initiative for Chronic Obstructive Lung Disease · Gold · Hospital Clínico San Carlos · Myriam Calle · Puerto del Rosario · SEPAR · Spanish Federation of Allergic and Respiratory Disease Patient Associations · Spanish Society of Pulmonology and Thoracic Surgery
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] In Italy, COPD affects approximately 3.5 million adults. www.estense.com · www.ilroma.net
- [○ 1 SOURCE] COPD caused 19,136 deaths in Mexico in 2024. rotativo.com.mx
- [○ 1 SOURCE] In Argentina, over 2 million people over age 40 may be affected by COPD. columnadigital.com
- [○ 1 SOURCE] Dupilumab and mepolizumab were approved for public funding in Spain in July 2026. efesalud.com
- [● 2 SOURCES] COPD is the third leading cause of death globally. columnadigital.com · www.chandigarhcitynews.com
- [● 2 SOURCES] The prevalence of COPD in Spain is 11.8% among the population over 40. www.consalud.es · diariosanitario.com
- [● 2 SOURCES] Approximately 75% of COPD cases in Spain remain undiagnosed. www.consalud.es · www.diarioestrategia.cl
- [○ 1 SOURCE] In Canada, about 80% of patients living with COPD are unaware of their diagnosis. www.healthing.ca